These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15324809)

  • 1. Design and validation of a bifunctional ligand display system for receptor targeting.
    Chen L; Zurita AJ; Ardelt PU; Giordano RJ; Arap W; Pasqualini R
    Chem Biol; 2004 Aug; 11(8):1081-91. PubMed ID: 15324809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hitting the target with bifunctional phage.
    Brown KC
    Chem Biol; 2004 Aug; 11(8):1033-5. PubMed ID: 15324803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hybrid vector for ligand-directed tumor targeting and molecular imaging.
    Hajitou A; Trepel M; Lilley CE; Soghomonyan S; Alauddin MM; Marini FC; Restel BH; Ozawa MG; Moya CA; Rangel R; Sun Y; Zaoui K; Schmidt M; von Kalle C; Weitzman MD; Gelovani JG; Pasqualini R; Arap W
    Cell; 2006 Apr; 125(2):385-98. PubMed ID: 16630824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of receptor ligands with phage display peptide libraries.
    Koivunen E; Arap W; Rajotte D; Lahdenranta J; Pasqualini R
    J Nucl Med; 1999 May; 40(5):883-8. PubMed ID: 10319765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection.
    Driessen WH; Bronk LF; Edwards JK; Proneth B; Souza GR; Decuzzi P; Pasqualini R; Arap W
    Adv Genet; 2010; 69():115-33. PubMed ID: 20807605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External surface display of proteins linked to DNA-binding domains.
    McGregor DP; Robins SP
    Anal Biochem; 2001 Jul; 294(2):108-17. PubMed ID: 11444805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency.
    Liu W; Kawahara M; Ueda H; Nagamune T
    Biotechnol Bioeng; 2008 Dec; 101(5):975-84. PubMed ID: 18500765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters affecting the display of antibodies on phage.
    Kirsch M; Zaman M; Meier D; Dübel S; Hust M
    J Immunol Methods; 2005 Jun; 301(1-2):173-85. PubMed ID: 15992816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
    Pameijer CR; Navanjo A; Meechoovet B; Wagner JR; Aguilar B; Wright CL; Chang WC; Brown CE; Jensen MC
    Cancer Gene Ther; 2007 Jan; 14(1):91-7. PubMed ID: 17024231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage as gene delivery vectors.
    Monaci P; Urbanelli L; Fontana L
    Curr Opin Mol Ther; 2001 Apr; 3(2):159-69. PubMed ID: 11338929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
    J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
    Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
    Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of display efficiency in yeast display system by vector engineering and gene disruption.
    Kuroda K; Matsui K; Higuchi S; Kotaka A; Sahara H; Hata Y; Ueda M
    Appl Microbiol Biotechnol; 2009 Mar; 82(4):713-9. PubMed ID: 19123001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
    Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW
    Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.
    Zang XP; Palwai NR; Lerner MR; Brackett DJ; Pento JT; Harrison RG
    Anticancer Res; 2006; 26(3A):1745-51. PubMed ID: 16827102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and selection of targeted adenoviruses embodying optimized vector properties.
    Noureddini SC; Krendelshchikov A; Simonenko V; Hedley SJ; Douglas JT; Curiel DT; Korokhov N
    Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
    Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
    Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting drugs to combinations of receptors: a modeling analysis of potential specificity.
    Caplan MR; Rosca EV
    Ann Biomed Eng; 2005 Aug; 33(8):1113-24. PubMed ID: 16133919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.